Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in plat (Q46417579)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in plat |
scientific article |
Statements
1 reference
Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in plat (English)
1 reference
Andrew L Frelinger
1 reference
Deepak L Bhatt
1 reference
Ronald D Lee
1 reference
Darcy J Mulford
1 reference
Jingtao Wu
1 reference
Sai Nudurupati
1 reference
Anu Nigam
1 reference
Michael Lampa
1 reference
Julie K Brooks
1 reference
Marc R Barnard
1 reference
Alan D Michelson
1 reference
16 January 2013
1 reference
61
1 reference
8
1 reference
872-879
1 reference
Identifiers
1 reference